Behavioral symptoms in patients with breast cancer and survivors

Journal of Clinical Oncology

Volumn 26, Issue 5, 2008, Pages 768-777

  Bower, Julienne E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CYTOKINE RECEPTOR ANTAGONIST; ERYTHROPOIETIN; ETANERCEPT; METHYLPHENIDATE; PAROXETINE; PLACEBO; PSYCHOSTIMULANT AGENT; TAMOXIFEN;

ANEMIA; BEHAVIOR; BREAST CANCER; CANCER PATIENT; CANCER SURVIVOR; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; FATIGUE; HUMAN; INSOMNIA; MEDICAL RESEARCH; METASTASIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYMPTOM; BREAST TUMOR; FEMALE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SURVIVOR;

BEHAVIORAL SYMPTOMS; BREAST NEOPLASMS; COGNITION DISORDERS; DEPRESSIVE DISORDER; FATIGUE; FEMALE; HUMANS; QUALITY OF LIFE; SLEEP INITIATION AND MAINTENANCE DISORDERS; SURVIVORS;

EID: 39149141405     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.3248     Document Type: Review

References (135)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55:10-30, 2005
2. Ganz PA: Why and how to study the fate of cancer survivors: Observations from the clinic and the research laboratory. Eur J Cancer 39:2136-2141, 2003
3. Patrick DL, Ferketich SL, Frame PS, et al: National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst 95:1110-1117, 2003
4. Curt GA, Breitbart W, Cella D, et al: Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 5:353-360, 2000
5. Lawrence DP, Kupelnick B, Miller K, et al: Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32:40-50, 2004
6. Servaes P, Verhagen C, Bleijenberg G: Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. Eur J Cancer 38:27-43, 2002
7. Andrykowski MA, Schmidt JE, Salsman JM, et al: Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 23:6613-6622, 2005
8. Donovan KA, Jacobsen PB, Andrykowski MA, et al: Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manage 28:373-380, 2004
9. Fan HG, Houede-Tchen N, Yi QL, et al: Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23:8025-8032, 2005
10. Bower JE, Ganz PA, Desmond KA, et al: Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743-753, 2000
11. Cella D, Davis K, Breitbart W, et al: Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385-3391, 2001
12. Bower JE, Ganz PA, Desmond KA, et al: Fatigue in long-term breast carcinoma survivors: A longitudinal investigation. Cancer 106:751-758, 2006
13. Servaes P, Gielissen MF, Verhagen S, et al: The course of severe fatigue in disease-free breast cancer patients: A longitudinal study. Psychooncology 16:787-795, 2006
14. Poulson MJ: Not just tired. J Clin Oncol 19:4180-4181, 2001
15. Andrykowski MA, Curran SL, Lightner R: Off-treatment fatigue in breast cancer survivors: A controlled comparison. J Behav Med 21:1-18, 1998
16. Jacobsen PB, Hann DM, Azzarello LM, et al: Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates. J Pain Symptom Manage 18:233-242, 1999
17. Groenvold M, Petersen MA, Idler E, et al: Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat 105:209-219, 2007
18. Wagner LI, Cella D: Fatigue and cancer: Causes, prevalence and treatment approaches. Br J Cancer 91:822-828, 2004
19. Jacobsen PB, Donovan KA, Weitzner MA: Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry 8:229-240, 2003
20. Visser MR, Smets EM: Fatigue, depression and quality of life in cancer patients: How are they related? Support Care Cancer 6:101-108, 1998
21. Capuron L, Gumnick JF, Musselman DL, et al: Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26:643-652, 2002
22. Jacobsen PB, Andrykowski MA, Thors CL: Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol 72:355-361, 2004
23. Broeckel JA, Jacobsen PB, Horton J, et al: Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689-1696, 1998
24. Ancoli-Israel S, Liu L, Marler MR, et al: Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 14:201-209, 2006
25. Donovan KA, Small BJ, Andrykowski MA, et al: Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol 26:464-472, 2007
26. Wratten C, Kilmurray J, Nash S, et al: Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys 59:160-167, 2004
27. Mills PJ, Parker B, Dimsdale JE, et al: The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 69:85-96, 2005
28. Bower JE, Ganz PA, Aziz N, et al: Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids. Brain Behav Immun 21:251-258, 2007
29. Bower JE, Ganz PA, Aziz N, et al: Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64:604-611, 2002
30. Bower JE, Ganz PA, Aziz N, et al: T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst 95:1165-1168, 2003
31. Collado-Hidalgo A, Bower JE, Ganz PA, et al: Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12:2759-2766, 2006
32. Bower JE, Ganz PA, Dickerson SS, et al: Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 30:92-100, 2005
33. Bower JE, Ganz PA, Aziz N: Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med 67:277-280, 2005
34. Cella D, Kallich J, McDermott A, et al: The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: Results from five randomized clinical trials. Ann Oncol 15:979-986, 2004
35. Mock V: Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr 32:112-118, 2004
36. McNeely ML, Campbell KL, Rowe BH, et al: Effects of exercise on breast cancer patients and survivors: A systematic review and meta-analysis. CMAJ 175:34-41, 2006
37. Pinto BM, Frierson GM, Rabin C, et al: Home-based physical activity intervention for breast cancer patients. J Clin Oncol 23:3577-3587, 2005
38. Courneya KS, Mackey JR, Bell GJ, et al: Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: Cardiopulmonary and quality of life outcomes. J Clin Oncol 21:1660-1668, 2003
39. Vallance JK, Courneya KS, Plotnikoff RC, et al: Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors. J Clin Oncol 25:2352-2359, 2007
40. Fairey AS, Courneya KS, Field CJ, et al: Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: A randomized controlled trial. Brain Behav Immun 19:381-388, 2005
41. Helgeson VS, Cohen S, Schulz R, et al: Education and peer discussion group interventions and adjustment to breast cancer. Arch Gen Psychiatry 56:340-347, 1999
42. Helgeson VS, Cohen S, Schulz R, et al: Long-term effects of educational and peer discussion group interventions on adjustment to breast cancer. Health Psychol 20:387-392, 2001
43. Spiegel D, Bloom JR, Yalom I: Group support for patients with metastatic cancer: A randomized outcome study. Arch Gen Psychiatry 38:527-533, 1981
44. Jacobsen PB, Meade CD, Stein KD, et al: Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol 20:2851-2862, 2002
45. Stanton AL, Ganz PA, Kwan L, et al: Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol 23:6009-6018, 2005
46. Courneya KS, Friedenreich CM, Quinney HA, et al: A longitudinal study of exercise barriers in colorectal cancer survivors participating in a randomized controlled trial. Ann Behav Med 29:147-153, 2005
47. Gielissen MF, Verhagen S, Witjes F, et al: Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: A randomized controlled trial. J Clin Oncol 24:4882-4887, 2006
48. Gielissen MF, Verhagen CA, Bleijenberg G: Cognitive behaviour therapy for fatigued cancer survivors: Long-term follow-up. Br J Cancer 97:612-618, 2007
49. Yates P, Aranda S, Hargraves M, et al: Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 23:6027-6036, 2005
50. Bower JE, Woolery A, Sternlieb B, et al: Yoga for cancer patients and survivors. Cancer Control 12:165-171, 2005
51. Morrow GR, Hickok JT, Roscoe JA, et al: Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21:4635-4641, 2003
52. Roscoe JA, Morrow GR, Hickok JT, et al: Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 89:243-249, 2005
53. Hanna A, Sledge G, Mayer ML, et al: A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer 14:210-215, 2006
54. Bruera E, Driver L, Barnes EA, et al: Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. J Clin Oncol 21:4439-4443, 2003
55. Bruera E, Valero V, Driver L, et al: Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073-2078, 2006
56. Monk JP, Phillips G, Waite R, et al: Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol 24:1852-1859, 2006
57. Madhusudan S, Muthuramalingam SR, Braybrooke JP, et al: Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer. J Clin Oncol 23:5950-5959, 2005
58. Madhusudan S, Foster M, Muthuramalingam SR, et al: A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. Clin Cancer Res 10:6528-6534, 2004
59. Fortner BV, Stepanski EJ, Wang SC, et al: Sleep and quality of life in breast cancer patients. J Pain Symptom Manage 24:471-480, 2002
60. Savard J, Simard S, Blanchet J, et al: Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 24:583-590, 2001
61. Couzi RJ, Helzlsouer KJ, Fetting JH: Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 13:2737-2744, 1995
62. Carpenter JS, Elam JL, Ridner SH, et al: Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31:591-5598, 2004
63. Koopman C, Nouriani B, Erickson V, et al: Sleep disturbances in women with metastatic breast cancer. Breast J 8:362-370, 2002
64. Fiorentino L, Ancoli-Israel S: Insomnia and its treatment in women with breast cancer. Sleep Med Rev 10:419-429, 2006
65. Silberfarb PM, Hauri PJ, Oxman TE, et al: Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol 11:997-1004, 1993
66. Savard J, Morin CM: Insomnia in the context of cancer: A review of a neglected problem. J Clin Oncol 19:895-908, 2001
67. Bardwell WA, Profant J, Casden DR, et al: The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology [epub ahead of print on April 11, 2007]
68. Savard J, Davidson JR, Ivers H, et al: The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 27:513-522, 2004
69. Rich T, Innominato PF, Boerner J, et al: Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 11:1757-1764, 2005
70. Morin CM, Culbert JP, Schwartz SM: Non-pharmacological interventions for insomnia: A meta-analysis of treatment efficacy. Am J Psychiatry 151:1172-1180, 1994
71. Murtagh DR, Greenwood KM: Identifying effective psychological treatments for insomnia: A meta-analysis. J Consult Clin Psychol 63:79-89, 1995
72. Irwin MR, Cole JC, Nicassio PM: Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol 25:3-14, 2006
73. Smith MT, Perlis ML, Park A, et al: Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 159:5-11, 2002
74. Savard J, Simard S, Ivers H, et al: Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol 23:6083-6096, 2005
75. Quesnel C, Savard J, Simard S, et al: Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consult Clin Psychol 71:189-200, 2003
76. Berger AM, VonEssen S, Khun BR, et al: Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 29:1431-1441, 2002
77. Berger AM, VonEssen S, Kuhn BR, et al: Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: Results of a feasibility intervention study. Oncol Nurs Forum 30:513-522, 2003
78. Davidson JR, Waisberg JL, Brundage MD, et al: Nonpharmacologic group treatment of insomnia: A preliminary study with cancer survivors. Psychooncology 10:389-397, 2001
79. Carlson LE, Speca M, Patel KD, et al: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 29:448-474, 2004
80. Shapiro SL, Bootzin RR, Figueredo AJ, et al: The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: An exploratory study. J Psychosom Res 54:85-91, 2003
81. Cohen L, Warneke C, Fouladi RT, et al: Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 100:2253-2260, 2004
82. Massie MJ: Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32:57-71, 2004
83. Coyne JC, Palmer SC, Shapiro PJ, et al: Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry 26:121-128, 2004
84. Schag CA, Ganz PA, Polinsky ML, et al: Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 11:783-793, 1993
85. Ganz PA, Rowland JH, Desmond K, et al: Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol 16:501-514, 1998
86. Bardwell WA, Natarajan L, Dimsdale JE, et al: Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 24:2420-2427, 2006
87. Ell K, Sanchez K, Vourlekis B, et al: Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 23:3052-3060, 2005
88. Spiegel D, Giese-Davis J: Depression and cancer: Mechanisms and disease progression. Biol Psychiatry 54:269-282, 2003
89. Gallo JJ, Bogner HR, Morales KH, et al: The effect of a primary care practice-based depression intervention on mortality in older adults: A randomized trial. Ann Intern Med 146:689-698, 2007
90. Epping-Jordan JE, Compas BE, Howell DC: Predictors of cancer progression in young adult men and women: Avoidance, intrusive thoughts, and psychological symptoms. Health Psychol 13:539-547, 1994
91. Stanton AL, Snider PR: Coping with a breast cancer diagnosis: A prospective study. Health Psychol 12:16-23, 1993
92. Kissane DW, Clarke DM, Ikin J, et al: Psychological morbidity and quality of life in Australian women with early-stage breast cancer: A cross-sectional survey. Med J Aust 169:192-196, 1998
93. Carver CS, Pozo C, Harris SD, et al: How coping mediates the effect of optimism on distress: A study of women with early stage breast cancer. J Pers Soc Psychol 65:375-390, 1993
94. Scheier MF, Helgeson VS: Really, disease doesn't matter? A commentary on correlates of depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 24:2407-2408, 2006
95. Giese-Davis J, Wilhelm FH, Conrad A, et al: Depression and stress reactivity in metastatic breast cancer. Psychosom Med 68:675-683, 2006
96. Musselman DL, Miller AH, Porter MR, et al: Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. Am J Psychiatry 158:1252-1257, 2001
97. Chochinov HM: Depression in cancer patients. Lancet Oncol 2:499-505, 2001
98. Kroenke K, Spitzer RL, Williams JB: The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 16:606-613, 2001
99. Martin A, Rief W, Klaiberg A, et al: Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry 28:71-77, 2006
100. Hollon SD, Stewart MO, Strunk D: Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol 57:285-315, 2006
101. Devine EC, Westlake SK: The effects of psychoeducational care provided to adults with cancer: Meta-analysis of 116 studies. Oncol Nurs Forum 22:1369-1381, 1995
102. Barsevick AM, Sweeney C, Haney E, et al: A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncol Nurs Forum 29:73-84, 2002
103. Meyer TJ, Mark MM: Effects of psychosocial interventions with adult cancer patients: A meta-analysis of randomized experiments. Health Psychol 14:101-108, 1995
104. Scheier MF, Helgeson VS, Schulz R, et al: Interventions to enhance physical and psychological functioning among younger women who are ending nonhormonal adjuvant treatment for early-stage breast cancer. J Clin Oncol 23:4298-4311, 2005
105. Antoni MH, Lehman JM, Klibourn KM, et al: Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 20:20-32, 2001
106. Classen C, Butler LD, Koopman C, et al: Supportive-expressive group therapy and distress in patients with metastatic breast cancer: A randomized clinical intervention trial. Arch Gen Psychiatry 58:494-501, 2001
107. Goodwin PJ, Leszcz M, Ennis M, et al: The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719-1726, 2001
108. Gill D, Hatcher S: Antidepressants for depression in medical illness. Cochrane Database Syst Rev 4:CD001312, 2000
109. Vardy J, Rourke S, Tannock IF: Evaluation of cognitive function associated with chemotherapy: A review of published studies and recommendations for future research. J Clin Oncol 25:2455-2463, 2007
110. Castellon SA, Ganz PA, Bower JE, et al: Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955-969, 2004
111. Falleti MG, Sanfilippo A, Maruff P, et al: The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain Cogn 59:60-70, 2005
112. Stewart A, Bielajew C, Collins B, et al: A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 20:76-89, 2006
113. van Dam FS, Schagen SB, Muller MJ, et al: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-218, 1998
114. Brezden CB, Phillips KA, Abdolell M, et al: Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695-2701, 2000
115. Schagen SB, van Dam FS, Muller MJ, et al: Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650, 1999
116. Tchen N, Juffs HG, Downie FP, et al: Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175-4183, 2003
117. Wefel JS, Lenzi R, Theriault RL, et al: The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer 100:2292-2299, 2004
118. Hurria A, Rosen C, Hudis C, et al: Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study. J Am Geriatr Soc 54:925-931, 2006
119. Bender CM, Sereika SM, Berga SL, et al: Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422-430, 2006
120. Schagen SB, Muller MJ, Boogerd W, et al: Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98:1742-1745, 2006
121. Jenkins V, Shilling V, Deutsch G, et al: A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828-834, 2006
122. Ahles TA, Saykin AJ, Furstenberg CT, et al: Neuropsychological impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485-493, 2002
123. Silverman DH, Dy CJ, Castellon SA, et al: Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 103:303-311, 2007
124. Inagaki M, Yoshikawa E, Matsuoka Y, et al: Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109:146-156, 2007
125. Yoshikawa E, Matsuoka Y, Inagaki M, et al: No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Res Treat 92:81-84, 2005
126. Ferguson RJ, McDonald BC, Saykin AJ, et al: Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy. J Clin Oncol 25:3866-3870, 2007
127. Ahles TA, Saykin AJ: Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192-201, 2007
128. Ahles TA, Saykin AJ, Noll WW, et al: The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12:612-619, 2003
129. Ferguson RJ, Ahles TA, Saykin AJ, et al: Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 16:772-777, 2007
130. Rozans M, Dreisbach A, Lertora JJ, et al: Palliative uses of methylphenidate in patients with cancer: A review. J Clin Oncol 20:335-339, 2002
131. Vogelzang NJ, Breitbart W, Cella D, et al: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey - The Fatigue Coalition. Semin Hematol 34:4-12, 1997
132. Buysse DJ, Reynolds CF III, Monk TH, et al: Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI). Sleep 14:331-338, 1991
133. Kumar N, Allen KA, Riccardi D, et al: Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: Is subclinical hypothyroidism the culprit? Breast Cancer Res Treat 83:149-159, 2004
134. Bower JE: Prevalence and causes of fatigue after cancer treatment: The next generation of research. J Clin Oncol 23:8280-8282, 2005
135. Miaskowski C, Dodd M, Lee K: Symptom clusters: The new frontier in symptom management research. J Natl Cancer Inst Monogr 32:17-21, 2004